Abstract
Background Recommended first-line management of lower limb osteoarthritis (OA) includes support for self-management, exercise and weight loss. However, many Australians with OA do not receive these. A National Osteoarthritis Strategy (the Strategy) was developed to outline a national plan to achieve optimal health outcomes for people at risk of, or with, OA. Objective The aim of this article is to identify priorities for action for Australians living with OA. Discussion The Strategy was developed in consultation with a leadership group, thematic working groups, an implementation advisory committee, multisectoral stakeholders and the public. Two priorities were identified by the ‘living well with OA' working group: 1) support primary care practitioners in the delivery of high-value care to Australians with OA, and 2) enhance the uptake of high-value care by Australians with OA. Evidence-informed strategies and implementation plans were developed through consultation to address these priorities.
| Original language | English |
|---|---|
| Pages (from-to) | 438-442 |
| Number of pages | 5 |
| Journal | Australian Journal of General Practice |
| Volume | 49 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2020 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
National Osteoarthritis Strategy brief report Living well with osteoarthritis. / Eyles, Jillian P.; Hunter, David J.; Briggs, Andrew M. et al.
In: Australian Journal of General Practice, Vol. 49, No. 7, 07.2020, p. 438-442.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - National Osteoarthritis Strategy brief report Living well with osteoarthritis
AU - Eyles, Jillian P.
AU - Hunter, David J.
AU - Briggs, Andrew M.
AU - Hinman, Rana S.
AU - Fitzpatrick, Jane
AU - March, Lyn
AU - Cicuttini, Flavia
AU - McNaughton, Sarah
AU - Ewald, Dan
AU - Nicholas, Michael
AU - Feng, Yingyu
AU - Filocamo, Karen
AU - Bennell, Kim
N1 - Funding Information: The National Osteoarthritis Strategy is endorsed by Arthritis Australia, the Australian Rheumatology Association, The Australian Orthopaedic Association, The Australasian College of Sport and Exercise Physicians and The Australian Prevention Partnership Centre. We acknowledge the funding support from the Medibank Better Health Foundation and the Australian Orthopaedic Association. The authors had full access to all relevant data in this study; the supporting sources had no involvement in data analysis and interpretation, or in the writing of the article. Professor David J Hunter holds an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship. Professor Andrew M Briggs holds an Australian NHMRC Fellowship (#1132548). Professor Rana S Hinman is supported by an NHMRC Fellowship (#1154217). Funding Information: Jillian P Eyles BAppSc (Physio), PhD, Research Fellow, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, NSW; Physiotherapist, Rheumatology Department, Royal North Shore Hospital, NSW. jillian.eyles@sydney.edu.au David J Hunter MBBS (Hons), MSc (Clin Epi), MSpMed, PhD, FRACP (Rheum), Florance and Cope Chair of Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, NSW; Consultant Rheumatologist, Rheumatology Department, Royal North Shore Hospital, NSW Andrew M Briggs BSc (Physio) (Hons), PhD, FACP, Professor, School of Physiotherapy and Exercise Science, Curtin University, WA Rana S Hinman BPhysio (Hons), PhD, Deputy Director, Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, University of Melbourne, Vic Jane Fitzpatrick PhD, MB.BS, FACSEP, Specialist Sports and Exercise Physician, Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, University of Melbourne, Vic Lyn March MBBS (Hons), MSc (Epi), PhD, FRACP (Rheum), FAFPHM, Liggins Professor of Rheumatology and Musculoskeletal Epidemiology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, NSW; Head of Department, Rheumatology Department, Royal North Shore Hospital, NSW Flavia Cicuttini MSc, MBBS, FRACP, PhD, Head of Musculoskeletal Unit, School of Public Health and Preventive Medicine, Monash University, Vic Sarah McNaughton PhD, Grad Dip (Nutr & Diet), BSc, FDAA, NHMRC Career Development Fellow, Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, VIC Dan Ewald BMed, MPH & TM, MAppEpid, FRACGP, FACTM, FAFPHM, General Practitioner, Lennox Head Medical Centre, NSW Michael Nicholas BSc, MSc (Hons), MPsychol (Clin), PhD, Director of Pain Education and Pain Management Program; Co-chair of Pain Management Network, Northern Clinical School, University of Sydney, NSW Yingyu Feng PhD, Research Fellow, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, NSW; Research Fellow, Rheumatology Department, Royal North Shore Hospital, NSW Karen Filocamo MHA, BA (Communication), Consumer representative, Northern Sydney Local Health District, NSW Kim Bennell BAppSc (Physio), PhD, Director, Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, University of Melbourne, Vic Competing interests: DJH reports personal fees as a consultant (advisory boards for Pfizer, Merck Serono, TLC Bio and Flexion), outside the submitted work. AMB reports grants from the Australian NHMRC during the conduct of the study. RSH reports grants from the NHMRC, ARC, Medibank and Asics Pty Ltd, outside the submitted work. JF reports personal fees from Bioventus LLC, outside the submitted work. FC is on the Osteoarthritis Research Society International Board and is a member of the Repatriation Medical Authority and AIHW National Arthritis and Musculoskeletal Monitoring Advisory Group. DE reports personal fees (part-time employment) from a Primary Health Network, as well as grants (research sponsorship) from Primary Health Network and Local Health District via Sydney University, outside the submitted work. He is also on the Editorial Committee of Handbook of NonDrug Intervention – The Royal Australian College of General Practitioners, which is referenced in the National Osteoarthritis Strategy. KF is a Board Member of Northern Sydney Local Health District. KB reports grants from the NHMRC and Medibank Private, outside the submitted work. Funding: The National Osteoarthritis Strategy receives funding support from the Medibank Better Health Foundation and the Australian Orthopaedic Association. Provenance and peer review: Not commissioned, externally peer reviewed. Publisher Copyright: © 2020 The Royal Australian College of General Practitioners. All Rights Reserved. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2020/7
Y1 - 2020/7
N2 - Background Recommended first-line management of lower limb osteoarthritis (OA) includes support for self-management, exercise and weight loss. However, many Australians with OA do not receive these. A National Osteoarthritis Strategy (the Strategy) was developed to outline a national plan to achieve optimal health outcomes for people at risk of, or with, OA. Objective The aim of this article is to identify priorities for action for Australians living with OA. Discussion The Strategy was developed in consultation with a leadership group, thematic working groups, an implementation advisory committee, multisectoral stakeholders and the public. Two priorities were identified by the ‘living well with OA' working group: 1) support primary care practitioners in the delivery of high-value care to Australians with OA, and 2) enhance the uptake of high-value care by Australians with OA. Evidence-informed strategies and implementation plans were developed through consultation to address these priorities.
AB - Background Recommended first-line management of lower limb osteoarthritis (OA) includes support for self-management, exercise and weight loss. However, many Australians with OA do not receive these. A National Osteoarthritis Strategy (the Strategy) was developed to outline a national plan to achieve optimal health outcomes for people at risk of, or with, OA. Objective The aim of this article is to identify priorities for action for Australians living with OA. Discussion The Strategy was developed in consultation with a leadership group, thematic working groups, an implementation advisory committee, multisectoral stakeholders and the public. Two priorities were identified by the ‘living well with OA' working group: 1) support primary care practitioners in the delivery of high-value care to Australians with OA, and 2) enhance the uptake of high-value care by Australians with OA. Evidence-informed strategies and implementation plans were developed through consultation to address these priorities.
UR - http://www.scopus.com/inward/record.url?scp=85087418067&partnerID=8YFLogxK
U2 - 10.31128/AJGP-08-19-5051-02
DO - 10.31128/AJGP-08-19-5051-02
M3 - Article
C2 - 32600001
AN - SCOPUS:85087418067
VL - 49
SP - 438
EP - 442
JO - Australian Journal of General Practice
JF - Australian Journal of General Practice
SN - 2208-794X
IS - 7
ER -